로딩 중…
지수 로딩 중…
aTyr Pharma, Inc.
ATYR· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$0.52+6.02%
2026-08-04
Financials
Valuation Metrics
aTyr Pharma, Inc.'s Market Cap is $51M. At end of 2025 it was $77M. Ranked #3099 of 3,112 in US market (top 100%), #1433 of 1,445 on NASDAQ (top 99%), #268 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 100%) by Market Cap.
Investment Metrics(as of 2026-08-04)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $51M | US#3,099/3,112 Sec#268/269 |
| Revenue | $190000.00 | US#2,970/3,112 Sec#202/269 |
| Net Income | $-70M | US—/3,112 Sec—/269 |
| Total Assets | $80M | US#3,045/3,112 Sec#266/269 |
| Net Assets | $58M | US#2,928/3,112 Sec#239/269 |
| Value | ||
| P/B | 0.88x | US#240/3,112 Sec#10/269 |
| P/S | 269.18x | US#2,929/3,112 Sec#191/269 |
| FCF Yield | -115.94% | US—/3,112 Sec—/269 |
| Profitability | ||
| ROE | -120.88% | US#2,875/3,112 Sec#226/269 |
| ROA | -87.92% | US#3,037/3,112 Sec#259/269 |
| Op. Margin | -38573.68% | US#2,970/3,112 Sec#202/269 |
| Revenue Growth | -19.15% | US#2,767/3,112 Sec#151/269 |
| Financial Health | ||
| Debt Ratio | 37.82% | US#430/3,112 Sec#122/269 |
| Total Debt | $12M | US#2,767/3,112 Sec#194/269 |
| FCF | $-59M | US#2,492/3,112 Sec#121/269 |
| Cash | $10M | US#2,943/3,112 Sec#266/269 |
| Current Ratio | 5.78x | US#417/3,112 Sec#133/269 |
| Performance | ||
| 1Y Return | -89.61% | US#3,125/3,112 Sec#268/269 |
| 1M Return | -11.97% | US#2,839/3,112 Sec#208/269 |
| From 52W High | -92.84% | US#3,118/3,112 Sec#271/269 |
| 1Y MDD | -94.01% | US#3,115/3,112 Sec#271/269 |
| Trading | ||
| Volume | 914,866 shares | US#1,734/3,112 Sec#168/269 |
| Trading Value | $476370.00 | US#3,088/3,112 Sec#266/269 |
| Per Share | ||
| EPS | $-0.76 | US—/3,112 Sec—/269 |
| BPS | $0.69 | US#2,661/3,112 Sec#212/269 |